
SVP Global Corp Comm at Ultragenyx, @JohnRitterFdn board member - also mother, beekeeper. I love science, curiosity and agents of change.
SF
Joined November 2008
- Tweets597
- Following469
- Followers693
- Likes1.6K
Carolyn Wang retweeted
#VirBiotechnology News: We announced positive updated Phase 1 data results for our PSMA-targeting, dual-masked #TCE VIR-5500 in participants with metastatic castration-resistant prostate cancer #mCRPC. Learn more in the replay of our conference call ➡️ bit.ly/4tefwtZ
Carolyn Wang retweeted
#VirBiotechnology News: We are proud to announce a global strategic collaboration with Astellas Pharma to advance our PSMA-targeting dual-masked T-cell engager #TCE VIR-5500 for the treatment of prostate cancer.➡️ bit.ly/4sbdI3K
Carolyn Wang retweeted
Bernie Sanders and AOC do a joint video explaining their view of the shutdown.
Carolyn Wang retweeted
We have people in power making broad claims around certain drugs and autism that have been continuously disproven. The degree to which those comments can undermine public health, do harm to women who are pregnant, create anxiety for parents who do have children who are autistic – is violence against the truth.
I'm on a call tonight called White Women: #AnswerTheCall2024 in support of Kamala. First off, there's a lot of us white women on this call... I cannot imagine what is happening over at @Zoom offices right now. I hope someone is delivering them food and liquids. You rock @Zoom!
Kamala just broke Zoom again.
Tonight's Zoom to support Kamala Harris is now the first EVER IN HISTORY to have over 100,000 participants.
#AnswerTheCall2024
Carolyn Wang retweeted
Ultragenyx $RARE gene therapy for rare liver ailment succeeds in late-stage trial statnews.com/2024/05/30/ultr… via @Jasonmmast
Carolyn Wang retweeted
Come and knock on our door, Joyce DeWitt and Priscilla Barnes! It was a Three's Company reunion at our Evening from the Heart event and @gma captured it: abcnews.go.com/GMA/Culture/t… #AortaEd #AortaSupporta #AorticDissection
Carolyn Wang retweeted
Thank you to Kaley Cuoco and the rest of the 8 Simple Rules family for supporting our Evening from the Heart last week! Kaley discusses one of her favorite memories of John with @people: people.com/kaley-cuoco-honor… #AortaEd #AortaSupporta #AorticDissection
Carolyn Wang retweeted
At #WorldOrphanUSA, our CEO, Dr. Emil Kakkis, will take the stage to deliver a keynote presentation on using biomarkers for #RareDiseases. Nicole Miller, VP of Molecular Diagnostics, will also take part in a panel on #NewbornScreening and the future for rare disease. More below.
Carolyn Wang retweeted
Company News: @ultragenyx's Emil Kakkis on this week's Angelman syndrome data, rare disease treatment modalities, and more.
Full video: biotechtv.com/post/ultrageny…
Carolyn Wang retweeted
Ultragenyx reports early success with Angelman syndrome drug, backing up 2022 acquisition statnews.com/2024/04/15/ultr… via @ADeAngelis_bio for @statnews
This workshop w/ participation from @US_FDA will drive an important discussion on applying the Accelerated Approval pathway for #rarediseases and will focus on #Sanfilippo Syndrome. There are a number of novel treatments on the line and many lives at stake. @ultragenyx
Our "Qualifying Biomarkers to Support Rare Disease Regulatory Pathways" hybrid public workshop agenda features over 15 experts & thought leaders from academic research, patient advocacy, drug development, & the @US_FDA.
View the full agenda & register: reaganudall.org/news-and-eve…
Carolyn Wang retweeted
"There are so many rare diseases that have no treatments at all," says @ultragenyx CEO Dr. Emil Kakkis, who says his company has been working to improve the process for the latest precision gene therapies, and is hopeful the FDA may use accelerated approvals for treatment.
Carolyn Wang retweeted
Today at the North America Rare Disease Summit 2023 (#NARDS), Ultragenyx team member Lisa Kahlman, executive director, public policy & public affairs, interviewed Dr. Peter Marks on his view of leveraging the Accelerated Approval pathway in #RareDisease.
Carolyn Wang retweeted
Ultragenyx announces new data from the investigative Phase 2/3 Orbit study of setrusumab (UX143) in #OsteogenesisImperfecta (OI) at #ASBMR23. Learn more: ultragenyx.co/3txZhxA
Carolyn Wang retweeted
Join us virtually on Monday, October 16 at 8:30 AM ET to hear from two researchers leading our #OsteogenesisImperfecta program during #AnalystDay. Watch the live webcast here: bit.ly/3tlGOnL
Carolyn Wang retweeted
For 20 years The JRF has worked to spread awareness of aortic health. Watch our video to learn more about the latest research developments and how you can help spread awareness of aortic dissection and save lives. youtu.be/oKxAExRX_us
Carolyn Wang retweeted
Today, we celebrate the opening of our #GeneTherapy manufacturing facility in Bedford, MA, which will enable us to bring cutting-edge gene therapies to transform the lives of people living with #RareDiseases. Learn more: ultragenyx.co/3PG13Wz
Carolyn Wang retweeted
In partnership with @MereoBiopharma, we’re pleased to share data from the dose-selection Phase 2 portion of our pivotal Orbit study for patients living with #OsteogenesisImperfecta (OI). Read the press release for more details: bit.ly/3CbO7PZ


















